Search...
/
The Fly Cast
Press play to listen
Competitive Advantages
Risks
Competitive Advantages
Diversified Product Portfolio & Market Focus: A broad range of products spanning generics, complex generics, biosimilars, and proprietary products, across multiple geographies like North America, Europe, India, and emerging markets, de-risks their business model.
Strong R&D Capabilities: Expertise in developing complex generics, biosimilars, and differentiated products allows them to capture higher-value opportunities and maintain a robust pipeline.
Extensive Global Footprint: Significant presence in key regulated markets (US, Europe) as well as a strong base in India and other emerging markets provides widespread market access and revenue streams.
Risks
Increased Regulatory Scrutiny: Ongoing inspections and potential enforcement actions from regulatory bodies like the FDA can lead to manufacturing disruptions, delays in product approvals, and reputational damage.
Intense Generic Competition: The pharmaceutical industry is highly competitive, with numerous players vying for market share, leading to pricing pressure and reduced profitability for generic drugs.
Product Pipeline and R&D Failures: The success of new product launches is crucial, but research and development efforts are inherently risky, with a high rate of clinical trial failures or inability to secure regulatory approvals.
Over a week ago
Jun 14, 5:09 PM
May 17, 11:41 AM
Apr 29, 7:40 AM
Apr 23, 1:43 PM
Apr 23, 1:38 PM
Apr 23, 11:59 AM
Feb 20, 10:58 AM
Aug 18, 8:20 AM
No more stories
